Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Primary Malignant Peripheral Nerve Sheath Tumors 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Leukemia, Myelomonocytic, Chronic 1GATA2 Deficiency 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 23fludarabine 15fludarabine phosphate 10Methotrexate 10blinatumomab 9Whole-Body Irradiation 9Vincristine 7Specimen Handling 7Dexamethasone 7merphos 6Tacrolimus 6Mycophenolic Acid 6Stem Cell Transplantation 5Peripheral Blood Stem Cell Transplantation 5Mesna 5Mercaptopurine 5Melphalan 5Leukapheresis 5Granulocyte Colony-Stimulating Factor 5Filgrastim 5Cytarabine 5Cyclosporine 5Biopsy 5pegaspargase 4Prednisone 4Magnetic Resonance Spectroscopy 4Etoposide 4Calcium Dobesilate 4Busulfan 4prednylidene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor Cell Lymphoblastic Leukemia-Lymphoma × Vorinostat × 30 days × Clear all
NCT05848687 2026-06-03

TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II

Stanford University

Phase 1/2 Recruiting
90 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡